Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories Revenue

In the fiscal year ending March 31, 2026, Ipca Laboratories had annual revenue of 96.46B INR with 7.89% growth. Ipca Laboratories had revenue of 23.88B in the quarter ending March 31, 2026, with 6.23% growth.

• Revenue: 96.46B
• Revenue Growth: +7.89%
• P/S Ratio: 4.17
• Revenue / Employee: 5.75M
• Employees: 16,778
• Market Cap: 402.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	96.46B	7.05B	7.89%
Mar 31, 2025	89.41B	12.35B	16.03%
Mar 31, 2024	77.06B	14.58B	23.33%
Mar 31, 2023	62.48B	4.18B	7.16%
Mar 31, 2022	58.31B	4.10B	7.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error